Intended Use

RayStation is a software system for radiation therapy and medical oncology. Based on user input, RayStation proposes treatment plans. After a proposed treatment plan is reviewed and approved by authorized intended users, RayStation may also be used to administer treatments. The system functionality can be configured based on user needs.

Technology

RayStation 11B is built on the same platform as its predicate device RayStation 11.0 but includes new features such as EQD2 dose computation, generation of synthetic CT from CBCT using two new algorithms, and computation of dose-weighted Linear Energy Transfer (LET) for proton and light ion plans. The system includes multiple applications for treatment planning, commissioning, and treatment administration.

Performance

Verification and validation activities included system tests, risk analysis, unit and subsystem testing, dose engine validation, and user validation in cooperation with cancer clinics. New features were validated with clinical and user site tests demonstrating dose computation accuracy adequate for clinical use. Overall, RayStation 11B met specifications and performed as safely and effectively as the predicate device.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    1/18/2022

    2 months
  • 2

    FDA Approval

    4/15/2022

Other devices from RaySearch Laboratories AB (publ)

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.